Infectious diseases

  • Director, Center for Infectious Disease Research and Policy (CIDRAP)
  • Regents Professor, Environmental Health Sciences, School of Public Health
  • Adjunct Professor, Division of Infectious Diseases and International Medicine
  • Department of Medicine, Medical School
  • Director, Minnesota Center of Excellence for Influenza Research and Surveillance (MCEIRS)

Michael Osterholm, PhD, MPH, investigates infectious disease outbreaks stateside and abroad, such as severe acute respiratory syndrome (SARS) and influenza. He is a member of the National Academy of Science Institute of Medicine and former state epidemiologist at the Minnesota Department of Health. He is a frequent consultant to the World Health Organization (WHO), the National Institutes of Health (NIH), the Food and Drug Administration (FDA), the Department of Defense, and the Centers for Disease Control and Prevention (CDC). 

  • Professor of Medicine, Division of Infectious Disease and International Medicine
  • Department of Medicine, Medical School
  • Director, Program in HIV Medicine
  • Director, Clinical and Translational Research Services

Timothy Schacker, MD, has developed an internationally recognized program in translational research focused on how HIV causes immune suppression. His team made the discovery of a process of inflammatory damage in lymphatic tissues. They are currently testing novel therapies to prevent and/or reverse this process as well as slow T cell depletion. Additionally, Dr. Schacker is the principal investigator of a federally funded project designed to determine barriers to HIV eradication. His research efforts have stretched to Uganda where he has collaborated with the Joint Clinical Research Center in Kampala to study how exposure to common infections affect rates of HIV transmission and progression. 

  • Professor, Department of Pediatrics, Medical School
  • Co-Director, Center for Infectious Diseases and Microbiology Translational Research (CIDMTR)

Mark Schleiss, MD, is a professor in the Department of Pediatrics and division director of Pediatric Infectious Diseases. Dr. Schleiss has received awards for his work and is a member of various research societies. Dr. Schleiss was also named one of the Best Doctors in America in 2011-2012, 2013. Dr. Schleiss focuses on the study of CMV (Cytomegalovirus) vaccines, immunopathogenesis, and placental infection. Currently, Schleiss’ lab is using animals to evaluate the extent of protection the maternal-placental-fetal unit provides against CMV.